The Myositis Association recognizes that the myositis patient’s best hope for a cure lies in research. TMA offers a research fellowship program to attract and encourage post-doctoral trainees (PhD and…
Continue Reading
Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the….
Today, Kezar Life Sciences announced topline results from the PRESIDIO study, evaluating the efficacy and safety of zetomipzomib in dermatomyositis and polymyositis. In this study, most patients experienced a clinically…
Continue Reading